Semaglutide

Product

GLP-1 receptor agonist peptide drug developed by Novo Nordisk, sold as Ozempic, Wegovy, and Rybelsus

3 stories

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

Eli Lilly's Obesity Drug Retatrutide Succeeds in Late-Stage Diabetes Trial

Two Deaths Reported to Regulators Potentially Linked to Weight-Loss Injections